193 related articles for article (PubMed ID: 7630147)
1. Effects of some novel D-myo-inositol-phosphate derivatives on binding and sympathetic transmission.
Sun XY; Edvinsson L; Yoo H; Wahlestedt C; Hedner T
J Cardiovasc Pharmacol; 1995 May; 25(5):696-704. PubMed ID: 7630147
[TBL] [Abstract][Full Text] [Related]
2. alpha-Trinositol: a functional (non-receptor) neuropeptide Y antagonist in vasculature.
Sun X; You J; Hedner T; Erlinge D; Fellström B; Yoo H; Wahlestedt C; Edvinsson L
J Pharm Pharmacol; 1996 Jan; 48(1):77-84. PubMed ID: 8722501
[TBL] [Abstract][Full Text] [Related]
3. D-myo-inositol-1,2,6-trisphosphate is a selective antagonist of neuropeptide Y-induced pressor responses in the pithed rat.
Sun XY; Dahlöf C; Edvinsson L; Hedner T
Eur J Pharmacol; 1991 Nov; 204(3):281-6. PubMed ID: 1773830
[TBL] [Abstract][Full Text] [Related]
4. A novel inositol phosphate selectively inhibits vasoconstriction evoked by the sympathetic co-transmitters neuropeptide Y (NPY) and adenosine triphosphate (ATP).
Wahlestedt C; Reis DJ; Yoo H; Adamsson M; Andersson D; Edvinsson L
Neurosci Lett; 1992 Aug; 143(1-2):123-6. PubMed ID: 1436655
[TBL] [Abstract][Full Text] [Related]
5. Effects of d-myo-inositol-1,2,6-trisphosphate on neuropeptide Y-induced potentiation of various vasoconstrictor agents in the rat.
Sun XY; Edvinsson L; Hedner T
J Pharmacol Exp Ther; 1992 Jun; 261(3):1147-52. PubMed ID: 1602380
[TBL] [Abstract][Full Text] [Related]
6. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C.
Bell D; Millar BC; McDermott BJ
Br J Pharmacol; 1997 Dec; 122(8):1655-60. PubMed ID: 9422811
[TBL] [Abstract][Full Text] [Related]
7. Autoradiographic localization and characterization of [3H]alpha-trinositol (1D-myo-inositol 1,2,6-trisphosphate) binding sites in human and mammalian tissues.
Walsh DA; Mapp PI; Polak JM; Blake DR
J Pharmacol Exp Ther; 1995 Apr; 273(1):461-9. PubMed ID: 7714802
[TBL] [Abstract][Full Text] [Related]
8. Characterization of specific binding sites for alpha-trinositol (D-myo-inositol 1,2,6-trisphosphate) in rat tissues.
Yoo H; Fallgren B; Lindahl A; Wahlestedt C
Eur J Pharmacol; 1994 Jun; 268(1):55-63. PubMed ID: 7925612
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y antagonistic properties of D-myo-inositol-1.2.6-trisphosphate in guinea pig basilar arteries.
Edvinsson L; Adamsson M; Jansen I
Neuropeptides; 1990 Oct; 17(2):99-105. PubMed ID: 2280824
[TBL] [Abstract][Full Text] [Related]
10. Histamine-independent modulation of the neuropeptide Y-induced pressor response by alpha-trinositol in the pithed rat.
Sun X; Edvinsson L; Hedner T
Pharmacol Toxicol; 1994 Dec; 75(6):371-6. PubMed ID: 7899259
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of alpha-trinositol in spontaneously hypertensive and normotensive Wistar-Kyoto rats.
Sun X; Edvinsson L; Hedner T
J Hypertens; 1993 Sep; 11(9):935-43. PubMed ID: 8254175
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of neuropeptide Y and its analogues on inositol 1,4,5-trisphosphate level in rat cardiomyocytes.
Xiang H; Brown JC
Recept Channels; 1993; 1(4):315-21. PubMed ID: 8081728
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and renal effects of alpha-trinositol in ischemic heart failure rats.
Sun XY; Feng QP; Zhao X; Edvinsson L; Hedner T
Life Sci; 1995; 57(12):1197-211. PubMed ID: 7674809
[TBL] [Abstract][Full Text] [Related]
14. alpha-Trinositol blocks neuropeptide Y-induced inositolphosphate formation in cerebral vessels.
Jansen I; You J; Edvinsson L
Neuropeptides; 1994 May; 26(5):305-12. PubMed ID: 8065548
[TBL] [Abstract][Full Text] [Related]
15. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J
Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354
[TBL] [Abstract][Full Text] [Related]
16. Semisynthetic derivatives of inositol 1,4,5-trisphosphate substituted at the 1-phosphate group. Effects on calcium release from permeabilized guinea-pig parotid acinar cells and comparison with binding to aldolase A.
Henne V; Mayr GW; Grabowski B; Koppitz B; Söling HD
Eur J Biochem; 1988 May; 174(1):95-101. PubMed ID: 3259506
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of neuropeptide Y-induced augmentation of noradrenaline-induced vasoconstriction by D-myo-inositol 1,2,6-trisphosphate in the rat mesenteric arterial bed.
Ralevic V; Edvinsson L; Burnstock G
Acta Physiol Scand; 1994 Jul; 151(3):309-17. PubMed ID: 7976403
[TBL] [Abstract][Full Text] [Related]
18. Molecular interactions of endogenous D-myo-inositol phosphates with the intracellular D-myo-inositol 1,4,5-trisphosphate recognition site.
Lu PJ; Gou DM; Shieh WR; Chen CS
Biochemistry; 1994 Sep; 33(38):11586-97. PubMed ID: 7918372
[TBL] [Abstract][Full Text] [Related]
19. Effects of liposome-entrapped D-myo-inositol 1,4,5-trisphosphate and D-myo-inositol 1,3,4,5-tetrakisphosphate in the isolated rat aorta.
Brailoiu E; Serban DN; Popescu LM; Slatineanu S; Filipeanu CM; Branisteanu DD
Eur J Pharmacol; 1993 Dec; 250(3):493-5. PubMed ID: 8112412
[TBL] [Abstract][Full Text] [Related]
20. Myo-inositol 1,3,4,5-tetrakisphosphate can independently mobilise intracellular calcium, via the inositol 1,4,5-trisphosphate receptor: studies with myo-inositol 1,4,5-trisphosphate-3-phosphorothioate and myo-inositol hexakisphosphate.
Wilcox RA; Whitham EM; Liu C; Potter BV; Nahorski SR
FEBS Lett; 1993 Dec; 336(2):267-71. PubMed ID: 8262243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
